Amplification was relatively higher in breast and non-small cell lung cancer (NSCLC) than in the other types of cancer and was correlated with higher amounts of Mcl-1 messenger RNA (mRNA) and unfavorable overall survival in patients (20). This evidence concerns the gene MCL1 and non-small cell lung carcinoma.